Marc Ferrante Selected Research

Biomarkers (Surrogate Marker)

10/2021	Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
1/2021	Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
2/2020	The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
1/2020	Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases.
11/2019	Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13.
2/2019	Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.
1/2019	TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?
10/2017	Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.
1/2017	The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study.
12/2015	Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Ferrante Research Topics

Disease

70	Crohn Disease (Crohn's Disease) 11/2022 - 12/2005
68	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022 - 09/2006
59	Ulcerative Colitis 11/2022 - 06/2006
23	Necrosis 01/2022 - 09/2011
20	Inflammation (Inflammations) 01/2022 - 09/2006
12	Colitis 10/2021 - 02/2007
11	Neoplasms (Cancer) 01/2022 - 02/2014
8	Infections 01/2022 - 02/2014
6	Fistula 11/2022 - 02/2010
6	Pouchitis 01/2021 - 01/2008
5	Fibrosis (Cirrhosis) 01/2020 - 09/2008
4	Disease Progression 12/2020 - 10/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2016
3	Dysbiosis 01/2022 - 08/2014
3	Abdominal Pain (Pain, Abdominal) 01/2022 - 12/2013
2	Rheumatoid Arthritis 01/2022 - 02/2014
2	Hemorrhage 01/2022 - 01/2020
2	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 12/2021 - 10/2006
2	Cystic Fibrosis (Mucoviscidosis) 11/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 09/2019
2	Ulcer 12/2018 - 01/2014
2	Ileitis 10/2018 - 06/2008
2	Iron Deficiencies 01/2017 - 12/2007
1	Choristoma (Ectopic Tissue) 11/2022
1	Diarrhea 06/2022
1	Collagenous Colitis 06/2022
1	Fatigue 05/2022
1	Asymptomatic Diseases 12/2021

Drug/Important Bio-Agent (IBA)

41	Infliximab (Remicade)FDA Link 08/2022 - 03/2006
20	vedolizumabIBA 08/2022 - 09/2017
19	Pharmaceutical PreparationsIBA 01/2022 - 10/2013
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 09/2008
14	AntibodiesIBA 12/2021 - 10/2007
13	Adalimumab (Humira)FDA Link 01/2022 - 11/2009
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2012
9	Biological ProductsIBA 08/2022 - 12/2009
9	Monoclonal AntibodiesIBA 12/2021 - 09/2008
8	SteroidsIBA 01/2022 - 06/2006
8	Immunologic Factors (Immunomodulators)IBA 10/2021 - 10/2013
7	golimumab FDA Link 01/2022 - 05/2016
7	Dextrans (Dextran)FDA Link 12/2020 - 01/2013
6	Ustekinumab (CNTO 1275)FDA Link 11/2022 - 07/2017
6	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2017
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2007
5	risankizumabIBA 01/2022 - 01/2017
5	SodiumIBA 12/2020 - 01/2013
5	CytokinesIBA 11/2019 - 01/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2010
4	Biosimilar PharmaceuticalsIBA 06/2020 - 01/2017
4	Tumor Necrosis Factor InhibitorsIBA 04/2018 - 01/2014
4	Phenobarbital (Luminal)FDA Link 02/2010 - 03/2006
3	CT-P13IBA 08/2022 - 01/2019
3	C-Reactive ProteinIBA 01/2022 - 01/2018
3	tofacitinibIBA 01/2022 - 05/2018
3	Janus Kinase InhibitorsIBA 01/2022 - 05/2018
3	Interleukin-12 (IL 12)IBA 07/2019 - 05/2018
3	IntegrinsIBA 01/2019 - 04/2018
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 07/2014
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 02/2014
3	PorinsIBA 06/2008 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 02/2014
2	mirikizumabIBA 01/2022 - 01/2020
2	InterleukinsIBA 01/2022 - 01/2019
2	ChloridesIBA 11/2021 - 10/2006
2	2-mercaptopurineIBA 01/2021 - 01/2020
2	AntigensIBA 09/2020 - 11/2007
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2020 - 12/2012
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 01/2018
2	Drinking WaterIBA 01/2020 - 01/2018
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2020 - 11/2019
2	Interleukin-17 (Interleukin 17)IBA 11/2019 - 05/2018
2	Butyrates (Butyrate)IBA 09/2019 - 08/2014
2	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2014
2	Azathioprine (Imuran)FDA LinkGeneric 03/2019 - 08/2015
2	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 11/2007
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
2	IronIBA 01/2017 - 12/2007
2	Peptides (Polypeptides)IBA 01/2017 - 10/2007
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 06/2006
2	Ferritins (Ferritin)IBA 01/2017 - 11/2005
2	ImmunosorbentsIBA 05/2016 - 07/2014
2	EnzymesIBA 05/2016 - 07/2014
2	LipocalinsIBA 12/2015 - 07/2014
2	Pattern Recognition ReceptorsIBA 06/2008 - 11/2007
2	Tranexamic Acid (AMCA)FDA Link 11/2007 - 10/2007
2	EpitopesIBA 11/2007 - 10/2007
1	Oncostatin MIBA 10/2021
1	SolutionsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021

Therapy/Procedure

69	Therapeutics 08/2022 - 11/2005
12	Biological Therapy 05/2022 - 12/2009
9	Restorative Proctocolectomy 06/2022 - 01/2008
7	Colectomy 10/2017 - 06/2006
1	Remission Induction 11/2022
1	Aftercare (After-Treatment) 11/2022
1	Bathroom Equipment 05/2022